Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Rande Is who wrote (3739)	2/22/1999 11:13:00 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 57584

ATRX---For a biotech with actual FDA approved products and earnings. The recently approved ATRIDOX product addresses a market that has a potential of 50 million people here in the US. Approval is coming in the next few weeks in Europe. Earnings will be released later this week and we will see the first results of this unique product.(ATRIDOX) Trading in stock over the past few days indicates that they will be good and more to come. For more information, I have a thread here on SI. Subject 25210